AngioScore completes its $12mm Series F round
Executive Summary
AngioScore Inc. (endovascular devices) has raised $12mm through what is believed to be its Series F venture round. New institutional investor Saints Capital led (and contributes a board member) and was joined by current backers, including Psilos Group Managers, Telegraph Hill Partners, QuestMark Partners, Pelion Venture Partners, California Technology Ventures, and Innomed Ventures, as well as 15 other undisclosed investors. Funds will be used to continue developing a 100mm AngioSculpt scoring balloon catheter for peripheral artery disease, a drug-coated AngioSculpt scoring balloon catheter, and an AngioSculpt scoring balloon for valvuloplasty and use in transaortic valve implantation procedures.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice